SCHEMBL2018808

SCHEMBL2018808

CCC(C)(C)[Si](C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL125812 0.84
SCHEMBL14146669 0.77
SCHEMBL14146676 0.77
SCHEMBL838455 0.76 TSHR (0.38)
SCHEMBL15214380 0.76 ALDH1A1 (0.33)
Tert-Pentylsilanetriol SCHEMBL838171 0.76
SCHEMBL839385 0.76 TSHR (0.38)
SCHEMBL686782 0.75
SCHEMBL18866726 0.73
SCHEMBL14557372 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148587-B1 CARBONITRILE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS PFIZER (US) 2021-02-24 EP disclosed
US-10328082-B2 Methods of use and combinations PFIZER INC. (US) 2019-06-25 US disclosed
WO-2017183043-A1 NOVEL PROCESS FOR THE PREPARATION OF TAVABOROLE, ITS NOVEL POLYMORPHIC FORMS AND THE POLYMORPHS THEREOF BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2017-10-26 WO disclosed
US-9777287-B2 Nucleotide sequences and corresponding polypeptides conferring modified phenotype characteristics in plants CERES, INC. (US) 2017-10-03 US disclosed
EP-2576492-B1 TREPROSTINIL PRODUCTION UNITED THERAPEUTICS CORP (US) 2017-09-20 EP disclosed
US-20170252352-A1 METHODS OF USE AND COMBINATIONS PFIZER INC. (US) 2017-09-07 US disclosed
US-9755204-B2 Separator, electrode element, electric energy storage device and method for producing separator NEC CORPORATION (JP) 2017-09-05 US disclosed
WO-2017143041-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY (US) 2017-08-24 WO disclosed
EP-2925725-B1 NOVEL SELECTIVE ANDROGEN RECEPTOR MODULATORS PFIZER (US) 2016-11-09 EP disclosed
US-9433621-B2 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections MERCK SHARP & DOHME CORP. (US) 2016-09-06 US disclosed
US-8762067-B2 Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data THE INVENTION SCIENCE FUND I, LLC (US) 2014-06-24 US disclosed
US-20140155390-A1 NOVEL SELECTIVE ANDROGEN RECEPTOR MODULATORS PFIZER INC. (US) 2014-06-05 US disclosed
US-8728436-B2 Synthesis strategy toward microspheric carbon coated off-stoichiometric lithium—iron—phosphorus compound materials HEFEI GUOXUAN HIGH-TECH POWER ENERGY CO., LTD. (CN) 2014-05-20 US disclosed
EP-2249829-B1 Tetrahydropyridoethers for treatment of age-related macular degeneration (AMD) KATAIRO GMBH (DE) 2014-03-12 EP disclosed
US-8545806-B2 Compositions and methods for biological remodeling with frozen particle compositions THE INVENTION SCIENCE FUND I, LLC (US) 2013-10-01 US disclosed
US-8541631-B2 Surface treatment method for solid material SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-09-24 US disclosed
US-20130171095-A1 Method for Purifying Antibodies XENCOR, INC. (US) 2013-07-04 US disclosed
US-20130144919-A1 TEMPLATE DEVELOPMENT BASED ON REPORTED ASPECTS OF A PLURALITY OF SOURCE USERS SEARETE LLC (US) 2013-06-06 US disclosed
EP-2341108-A1 Surface treatment method for solid material Shin-Etsu Chemical Co., Ltd. (JP) 2011-07-06 EP disclosed
US-20110160464-A1 SURFACE TREATMENT METHOD FOR SOLID MATERIAL SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-06-30 US disclosed